2.55
+0.02(+0.79%)
Currency In USD
| Previous Close | 2.53 |
| Open | 2.47 |
| Day High | 2.57 |
| Day Low | 2.47 |
| 52-Week High | 4.18 |
| 52-Week Low | 2.21 |
| Volume | 19,405 |
| Average Volume | 54,056 |
| Market Cap | 8.76M |
| PE | -0.76 |
| EPS | -3.36 |
| Moving Average 50 Days | 2.66 |
| Moving Average 200 Days | 3.01 |
| Change | 0.02 |
If you invested $1000 in Kiora Pharmaceuticals, Inc. (KPRX) since IPO date, it would be worth $0.18 as of October 31, 2025 at a share price of $2.55. Whereas If you bought $1000 worth of Kiora Pharmaceuticals, Inc. (KPRX) shares 4 years ago, it would be worth $2.08 as of October 31, 2025 at a share price of $2.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025
Newsfile
Oct 15, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - October 15, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that it will participate in an ophthalmology panel at the upcoming 2025 Maxim Growth Summit in New York and give an overview of it
Kiora Pharmaceuticals to Webcast On-Demand Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
Newsfile
Sep 04, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - September 4, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its Chief Financial Officer, Melissa Tosca, CPA, will showcase the Company's pipeline of therapies targeting inherited and i
Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Newsfile
Aug 07, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - August 7, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its President and CEO, Brian M. Strem, Ph.D., will showcase the Company's pipeline of therapies targeting inherited and inflamm